Takeda Completes Russian Plant Aiming For 15% Annual Generics Sales
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical said it has completed construction of a $95.7 million production plant in Russia as part of a plan to increase sales there by 15% per year over the next four years.